Glaxosmithkline Pharmaceuticals, 500660, GLAXO Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

24,397.01
54.19
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

23,226.25
1.39%
10.81

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
-1.33
2.53

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
1.29
7.63

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-2.04
8.09

P:E (Median)

8 Years
5 Years
3 Years

56.35
67.03
62.51

P:BV (Average)

8 Years
5 Years
3 Years

11.02
12.25
11.08

EV:EBITDA (Average)

8 Years
5 Years
3 Years

32.03
38.79
37.24

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 19 Jun 18 Var% Mar 19 Mar 18 Var% Dec 18 Dec 17 Var% Sep 18 Sep 17 Var%
Net Sales 788.02 735.65 7.12% 751.22 748.62 0.35% 825.35 703.91 17.25% 816.31 836.26 -2.39%
Expenses 622.54 595.28 4.58% 587.59 593.76 -1.04% 688.03 562.10 22.40% 651.15 644.17 1.08%
EBITDA 165.48 140.37 17.89% 163.63 154.86 5.66% 137.32 141.81 -3.17% 165.16 192.09 -14.02%
EBIDTM 21.00% 19.08% 21.78% 20.69% 16.64% 20.15% 20.23% 22.97%
Other Income 30.54 17.78 71.77% 52.46 18.30 186.67% 16.42 11.99 36.95% 14.82 9.63 53.89%
Interest 0.93 0.20 365.00% 0.08 0.19 -57.89% 0.05 0.04 25.00% 0.22 0.02 1,000.00%
Depreciation 19.06 11.36 67.78% 13.68 9.36 46.15% 12.04 13.38 -10.01% 11.51 7.73 48.90%
PBT 176.03 138.31 27.27% 199.16 163.61 21.73% 169.78 140.38 20.94% 156.46 199.13 -21.43%
Tax 62.57 49.72 25.84% 76.13 58.06 31.12% 56.81 50.69 12.07% 55.69 68.81 -19.07%
PAT 113.46 88.59 28.07% 123.03 105.55 16.56% 112.97 89.69 25.96% 100.77 130.32 -22.67%
PATM 14.40% 12.04% 16.38% 14.10% 13.69% 12.74% 12.34% 15.58%
EPS 6.70 5.23 28.11% 7.26 6.23 16.53% 6.67 5.29 26.09% 5.95 7.69 -22.63%

Description Jun 19 Jun 18 Var% Mar 19 Mar 18 Var% Dec 18 Dec 17 Var% Sep 18 Sep 17 Var%
Net Sales 787.97 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Expenses 622.68 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBITDA 165.29 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIDTM 20.98% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 30.81 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest 0.93 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 19.06 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 176.11 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Tax 62.57 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 113.54 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PATM 14.41% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 6.70 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13 Dec 12 Dec 11 Dec 10 Dec 09
Net Sales 3,180.90 3,128.53 2,871.69 2,902.99 2,826.21 3,345.97 2,591.16 2,671.83 2,416.86 2,111.64 1,870.77 Net Sales Growth 5.17% 8.94% -1.08% 2.72% -15.53% 29.13% -3.02% 10.55% 14.45% 12.88% Cost Of Goods Sold 1,367.58 1,353.53 1,240.75 1,393.77 1,318.65 1,322.83 1,166.02 1,094.24 912.83 774.61 690.35 Gross Profit 1,813.32 1,775.01 1,630.93 1,509.22 1,507.56 2,023.14 1,425.14 1,577.58 1,504.03 1,337.03 1,180.42 GP Margin 57.01% 56.74% 56.79% 51.99% 53.34% 60.46% 55.00% 59.04% 62.23% 63.32% 63.10% Total Expenditure 2,549.31 2,522.05 2,363.25 2,483.05 2,349.46 2,777.18 2,114.09 1,901.95 1,675.46 1,459.69 1,307.15 Power & Fuel Cost - 27.94 26.44 27.82 25.97 31.17 23.85 22.50 26.70 26.75 24.66 % Of Sales - 0.89% 0.92% 0.96% 0.92% 0.93% 0.92% 0.84% 1.10% 1.27% 1.32% Employee Cost - 537.20 523.40 483.01 443.37 493.02 362.05 295.52 278.36 234.53 203.97 % Of Sales - 17.17% 18.23% 16.64% 15.69% 14.73% 13.97% 11.06% 11.52% 11.11% 10.90% Manufacturing Exp. - 115.19 110.55 108.26 117.67 365.85 127.72 113.57 111.16 67.08 59.67 % Of Sales - 3.68% 3.85% 3.73% 4.16% 10.93% 4.93% 4.25% 4.60% 3.18% 3.19% General & Admin Exp. - 178.51 203.43 194.72 154.34 177.98 134.79 125.55 107.78 144.41 129.42 % Of Sales - 5.71% 7.08% 6.71% 5.46% 5.32% 5.20% 4.70% 4.46% 6.84% 6.92% Selling & Distn. Exp. - 202.81 154.38 178.88 164.26 222.32 186.27 160.50 157.41 140.83 131.12 % Of Sales - 6.48% 5.38% 6.16% 5.81% 6.64% 7.19% 6.01% 6.51% 6.67% 7.01% Miscellaneous Exp. - 106.88 104.29 96.61 125.19 164.01 113.38 90.07 81.22 70.91 131.12 % Of Sales - 3.42% 3.63% 3.33% 4.43% 4.90% 4.38% 3.37% 3.36% 3.36% 3.84% EBITDA 631.59 606.48 508.44 419.94 476.75 568.79 477.07 769.88 741.40 651.95 563.62 EBITDA Margin 19.86% 19.39% 17.71% 14.47% 16.87% 17.00% 18.41% 28.81% 30.68% 30.87% 30.13% Other Income 114.24 101.48 53.52 72.01 122.25 257.53 246.31 243.07 200.93 233.56 211.60 Interest 1.28 0.55 0.19 0.25 0.42 0.47 0.33 0.33 0.33 0.62 0.37 Depreciation 56.29 48.59 37.99 26.35 24.95 25.35 19.88 17.84 20.41 17.63 16.37 PBT 701.43 658.82 523.78 465.35 573.63 800.50 703.17 994.78 921.60 867.27 758.48 Tax 251.20 238.35 189.60 174.30 201.41 276.98 227.44 269.30 168.45 285.88 253.59 Tax Rate 35.81% 35.91% 35.01% 34.10% 34.97% 37.00% 31.19% 31.81% 28.12% 32.96% 33.43% PAT 450.23 425.36 351.99 336.78 374.53 471.65 501.88 577.26 430.60 581.38 504.89 PAT before Minority Interest 450.23 425.36 351.99 336.78 374.53 471.65 501.88 577.26 430.60 581.38 504.89 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 14.15% 13.60% 12.26% 11.60% 13.25% 14.10% 19.37% 21.61% 17.82% 27.53% 26.99% PAT Growth 8.71% 20.84% 4.52% -10.08% -20.59% -6.02% -13.06% 34.06% -25.93% 15.15% Unadjusted EPS 26.58 25.11 41.56 39.76 44.22 55.68 59.25 68.15 50.84 66.55 60.48

Description TTM Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13 Dec 12 Dec 11 Dec 10 Dec 09
Net Sales - 3,128.12 2,871.45 2,908.47 2,837.91 3,362.91 2,607.70 2,692.06 2,455.38 2,151.06 1,907.77 Net Sales Growth - 8.94% -1.27% 2.49% -15.61% 28.96% -3.13% 9.64% 14.15% 12.75% Cost Of Goods Sold - 1,358.03 1,241.31 1,397.75 1,324.90 1,327.66 1,171.68 1,100.57 923.50 785.73 700.01 Gross Profit - 1,770.09 1,630.14 1,510.72 1,513.02 2,035.25 1,436.02 1,591.49 1,531.87 1,365.33 1,207.75 GP Margin - 56.59% 56.77% 51.94% 53.31% 60.52% 55.07% 59.12% 62.39% 63.47% 63.31% Total Expenditure - 2,527.32 2,365.66 2,489.49 2,359.64 2,788.33 2,124.49 1,915.22 1,693.90 1,478.25 1,324.67 Power & Fuel Cost - 27.94 26.44 27.82 25.97 31.17 23.85 22.50 26.70 26.75 24.66 % Of Sales - 0.89% 0.92% 0.96% 0.92% 0.93% 0.91% 0.84% 1.09% 1.24% 1.29% Employee Cost - 537.20 523.40 483.01 443.37 493.02 362.05 295.52 278.36 234.53 203.97 % Of Sales - 17.17% 18.23% 16.61% 15.62% 14.66% 13.88% 10.98% 11.34% 10.90% 10.69% Manufacturing Exp. - 115.55 110.55 108.26 118.09 367.24 127.78 113.62 111.44 67.51 60.08 % Of Sales - 3.69% 3.85% 3.72% 4.16% 10.92% 4.90% 4.22% 4.54% 3.14% 3.15% General & Admin Exp. - 178.60 203.53 195.08 154.85 178.21 135.34 126.10 108.51 145.09 130.13 % Of Sales - 5.71% 7.09% 6.71% 5.46% 5.30% 5.19% 4.68% 4.42% 6.75% 6.82% Selling & Distn. Exp. - 202.81 154.38 178.91 164.47 222.31 186.23 160.74 157.60 140.85 131.33 % Of Sales - 6.48% 5.38% 6.15% 5.80% 6.61% 7.14% 5.97% 6.42% 6.55% 6.88% Miscellaneous Exp. - 107.20 106.05 98.67 127.99 168.72 117.55 96.17 87.78 72.33 131.33 % Of Sales - 3.43% 3.69% 3.39% 4.51% 5.02% 4.51% 3.57% 3.58% 3.36% 3.84% EBITDA - 600.80 505.79 418.98 478.27 574.58 483.21 776.84 761.48 672.81 583.10 EBITDA Margin - 19.21% 17.61% 14.41% 16.85% 17.09% 18.53% 28.86% 31.01% 31.28% 30.56% Other Income - 102.32 54.54 73.07 123.18 258.80 222.30 223.90 186.59 217.06 194.80 Interest - 0.55 0.19 0.25 0.42 0.47 0.33 0.33 0.33 0.62 0.37 Depreciation - 48.59 37.99 26.35 24.95 25.35 19.88 17.84 20.41 17.63 16.37 PBT - 653.97 522.17 465.46 576.08 807.56 685.30 982.58 927.33 871.62 761.16 Tax - 237.28 189.24 174.37 202.25 279.27 229.78 272.48 176.20 293.35 260.70 Tax Rate - 34.76% 35.05% 34.11% 34.97% 36.96% 32.30% 32.66% 29.13% 33.66% 34.25% PAT - 445.39 350.73 336.81 376.14 476.41 481.67 561.88 428.59 578.27 500.46 PAT before Minority Interest - 445.39 350.73 336.81 376.14 476.41 481.67 561.88 428.59 578.27 500.46 Minority Interest - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin - 14.24% 12.21% 11.58% 13.25% 14.17% 18.47% 20.87% 17.46% 26.88% 26.23% PAT Growth - 26.99% 4.13% -10.46% -21.05% -1.09% -14.28% 31.10% -25.88% 15.55% Unadjusted EPS - 26.29 41.41 39.76 44.41 56.24 56.87 66.34 50.60 66.18 59.96

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13 Dec 12 Dec 11 Dec 10 Dec 09
Shareholder's Funds 2,142.42 2,079.95 2,028.21 2,204.64 1,851.67 2,017.19 2,010.02 1,919.93 1,930.81 1,759.15 Share Capital 169.41 84.70 84.70 84.70 84.70 84.70 84.70 84.70 84.70 84.70 Total Reserves 1,973.01 1,995.25 1,943.51 2,119.94 1,766.97 1,932.49 1,925.31 1,835.23 1,846.11 1,674.45 Non-Current Liabilities 2,835.06 185.97 184.17 190.35 195.96 157.51 157.36 171.68 -51.23 -39.27 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.18 0.58 0.99 1.60 2.63 3.61 4.14 4.59 5.16 5.42 Long Term Provisions 2,893.17 286.20 271.00 283.90 270.96 241.04 234.79 223.56 0.00 0.00 Current Liabilities 2,800.62 1,596.04 717.46 574.86 1,105.86 883.07 835.75 857.98 3,120.66 2,668.86 Trade Payables 402.96 502.53 275.92 323.09 305.89 278.01 235.19 198.34 331.92 291.38 Other Current Liabilities 802.59 842.33 391.18 203.59 131.56 86.22 88.35 68.37 14.30 25.29 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 1,595.07 251.18 50.36 48.18 668.42 518.83 512.21 591.28 2,774.44 2,352.19 Total Liabilities 7,778.10 3,861.96 2,929.84 2,969.85 3,153.49 3,057.77 3,003.13 2,949.59 5,000.24 4,388.74 Net Block 429.99 322.81 252.71 204.04 123.06 100.07 89.40 99.13 108.93 92.81 Gross Block 559.05 405.89 299.09 228.36 319.19 299.08 272.04 271.66 318.40 289.18 Accumulated Depreciation 129.06 83.08 46.38 24.32 196.13 199.01 182.63 172.53 209.47 196.37 Non Current Assets 4,437.17 1,698.91 1,280.00 822.06 588.30 456.03 390.73 380.12 278.01 305.08 Capital Work in Progress 1,002.64 922.90 605.46 267.67 115.22 61.86 43.79 16.19 8.72 21.36 Non Current Investment 26.17 49.43 52.99 53.63 47.67 47.67 57.68 102.59 160.35 190.91 Long Term Loans & Adv. 2,970.52 399.30 364.78 296.66 291.23 232.87 189.69 152.93 0.00 0.00 Other Non Current Assets 7.84 4.47 4.05 0.06 11.12 13.55 10.18 9.27 0.00 0.00 Current Assets 3,340.93 2,163.05 1,649.84 2,147.80 2,565.18 2,601.73 2,612.40 2,569.48 4,722.23 4,083.66 Current Investments 0.00 0.00 0.00 0.00 0.00 10.00 44.91 57.21 0.00 0.00 Inventories 486.49 500.18 425.48 521.66 368.86 342.40 282.04 330.14 281.54 253.02 Sundry Debtors 120.49 146.96 170.80 126.56 100.32 96.39 115.90 85.31 47.03 53.73 Cash & Bank 1,155.33 1,279.69 882.23 1,377.68 1,898.02 2,027.14 2,038.78 1,984.09 1,948.08 1,672.60 Other Current Assets 1,578.61 42.85 51.50 23.24 197.99 125.80 130.77 112.73 2,445.59 2,104.30 Short Term Loans & Adv. 1,466.65 193.36 119.84 98.66 109.61 68.16 55.79 49.40 2,392.77 2,074.77 Net Current Assets 540.31 567.01 932.39 1,572.94 1,459.32 1,718.67 1,776.65 1,711.50 1,601.57 1,414.80 Total Assets 7,778.10 3,861.96 2,929.84 2,969.86 3,153.48 3,057.76 3,003.13 2,949.60 5,000.24 4,388.74

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13 Dec 12 Dec 11 Dec 10 Dec 09
Shareholder's Funds 2,139.83 2,057.33 2,006.86 2,183.25 1,828.98 1,989.73 2,006.83 1,935.70 1,951.58 1,786.09 Share Capital 169.41 84.70 84.70 84.70 84.70 84.70 84.70 84.70 84.70 84.70 Total Reserves 1,970.42 1,972.63 1,922.15 2,098.55 1,744.28 1,905.03 1,922.13 1,851.00 1,866.88 1,701.39 Non-Current Liabilities 2,860.37 2,632.47 3,699.70 3,498.32 197.04 158.59 158.45 172.78 -51.43 -39.47 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.18 0.58 0.99 1.60 2.63 3.61 4.14 4.59 5.16 5.42 Long Term Provisions 2,920.20 2,733.36 3,786.83 3,592.19 272.21 242.29 236.05 224.81 0.00 0.00 Current Liabilities 2,804.07 1,599.86 720.23 783.63 1,106.55 888.91 836.40 859.59 3,179.07 2,718.89 Trade Payables 405.81 505.86 278.93 327.74 308.04 285.63 237.37 200.58 334.36 294.42 Other Current Liabilities 802.71 842.35 390.47 202.82 130.09 84.13 86.82 67.25 12.60 22.78 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 1,595.54 251.66 50.83 253.08 668.42 519.15 512.21 591.77 2,832.12 2,401.69 Total Liabilities 7,804.27 6,289.66 6,426.79 6,465.20 3,132.57 3,037.23 3,001.68 2,968.07 5,079.22 4,465.51 Net Block 429.99 322.81 252.71 204.04 123.08 100.09 89.42 99.15 108.95 92.83 Gross Block 559.05 405.89 299.09 228.36 363.34 343.22 316.18 315.80 362.54 333.32 Accumulated Depreciation 129.06 83.08 46.38 24.32 240.26 243.13 226.76 216.65 253.59 240.49 Non Current Assets 4,445.06 4,103.26 4,752.54 4,087.05 545.58 413.30 355.01 363.01 235.57 262.64 Capital Work in Progress 1,002.64 922.90 605.46 267.67 115.22 61.86 43.79 16.19 8.72 21.36 Non Current Investment 1.69 1.84 5.40 6.04 0.06 0.06 10.06 54.98 117.90 148.46 Long Term Loans & Adv. 3,002.88 2,855.66 3,888.91 3,609.24 296.09 237.73 194.55 157.01 0.00 0.00 Other Non Current Assets 7.84 0.06 0.06 0.06 11.13 13.55 17.19 35.68 0.00 0.00 Current Assets 3,359.21 2,186.41 1,674.25 2,378.15 2,586.98 2,623.94 2,646.67 2,605.06 4,843.65 4,202.88 Current Investments 0.00 0.00 0.00 0.00 0.00 10.00 44.91 57.21 0.00 0.00 Inventories 486.49 500.18 425.80 525.87 375.58 346.97 285.15 333.44 285.55 257.30 Sundry Debtors 120.49 146.96 170.80 126.56 100.32 96.39 115.90 85.31 47.03 53.73 Cash & Bank 1,171.35 1,296.41 899.61 1,391.90 1,910.61 2,041.58 2,066.77 2,014.36 2,002.89 1,733.90 Other Current Assets 1,580.88 43.34 52.27 23.24 200.47 128.99 133.94 114.74 2,508.18 2,157.95 Short Term Loans & Adv. 1,468.58 199.52 125.77 310.58 112.04 71.19 58.18 50.12 2,454.34 2,127.55 Net Current Assets 555.14 586.54 954.01 1,594.52 1,480.43 1,735.03 1,810.27 1,745.46 1,664.58 1,483.98 Total Assets 7,804.27 6,289.67 6,426.79 6,465.20 3,132.56 3,037.24 3,001.68 2,968.07 5,079.22 4,465.52

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13 Dec 12 Dec 11 Dec 10 Dec 09
Cash From Operating Activity 401.07 474.77 232.28 138.27 340.88 267.42 293.63 321.56 467.55 503.30 PBT 658.82 523.78 465.35 573.63 800.50 703.17 994.78 921.60 867.27 758.48 Adjustment -30.52 -11.15 -45.42 -95.08 -172.39 -180.38 -178.80 -153.72 -105.04 -85.01 Changes in Working Capital -7.58 163.69 -29.47 -125.04 -30.17 1.66 38.79 -74.06 11.06 22.22 Cash after chg. in Working capital 620.71 676.33 390.46 353.51 597.94 524.44 854.76 693.82 773.29 695.70 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -204.26 -201.82 -160.86 -204.42 -250.13 -242.05 -313.81 -309.30 -304.67 -177.43 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items -15.38 0.25 2.67 -10.82 -6.93 -14.97 -247.33 -62.96 -1.06 -14.97 Cash From Investing Activity -144.33 -107.01 303.08 499.09 177.62 197.98 -92.58 368.48 101.99 654.82 Net Fixed Assets -232.90 -424.24 -408.52 -61.62 -73.47 -45.11 -27.98 39.27 -16.58 -18.44 Net Investments 23.26 3.56 0.64 -5.96 10.00 44.92 57.21 0.55 30.56 560.97 Others 65.31 313.67 710.96 566.67 241.09 198.17 -121.81 328.66 88.01 112.29 Cash from Financing Activity -358.36 -306.63 -510.76 -638.33 -496.99 -490.08 -437.07 -391.82 -294.09 -391.77 Net Cash Inflow / Outflow -101.62 61.12 24.59 -0.98 21.51 -24.68 -236.01 298.22 275.46 766.35 Opening Cash & Equivalents 199.40 138.27 113.68 114.66 93.50 137.07 373.08 74.86 1,672.73 906.39 Closing Cash & Equivalent 97.78 199.40 138.27 113.68 115.01 112.39 137.07 373.08 1,948.19 1,672.73

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13 Dec 12 Dec 11 Dec 10 Dec 09
Cash From Operating Activity 399.38 472.80 234.37 138.90 337.64 281.31 313.59 335.37 479.36 511.51 PBT 653.97 522.17 465.46 576.08 807.56 685.30 982.58 927.33 871.62 761.16 Adjustment -31.36 -12.17 -46.47 -96.01 -173.66 -156.37 -159.63 -139.38 -89.96 -69.78 Changes in Working Capital -4.19 164.56 -26.69 -124.41 -36.90 11.45 56.35 -73.09 12.66 20.47 Cash after chg. in Working capital 618.41 674.55 392.29 355.67 597.00 540.37 879.30 714.86 794.32 711.85 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -204.34 -202.01 -160.59 -205.95 -252.43 -244.09 -318.38 -316.53 -313.89 -185.38 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items -14.69 0.25 2.67 -10.82 -6.93 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -143.34 -104.19 300.64 499.02 180.01 188.98 -109.65 358.03 86.76 660.78 Net Fixed Assets -232.90 -424.24 -408.52 -61.62 -73.47 -45.11 -27.98 39.27 -16.58 -18.44 Net Investments 23.26 3.56 0.64 -5.96 10.00 44.92 57.21 0.55 30.56 560.97 Others 66.30 316.49 708.52 566.60 243.48 189.17 -138.88 318.21 72.78 118.25 Cash from Financing Activity -358.36 -306.63 -510.76 -638.33 -496.99 -494.14 -440.63 -394.81 -297.15 -394.84 Net Cash Inflow / Outflow -102.33 61.97 24.24 -0.42 20.66 -23.85 -236.69 298.59 268.97 777.45 Opening Cash & Equivalents 201.10 139.13 114.89 115.30 94.93 137.67 374.36 75.77 1,734.03 956.58 Closing Cash & Equivalent 98.78 201.10 139.13 114.89 115.59 113.82 137.67 374.36 2,003.01 1,734.03

Financial Ratios

Consolidated /

Standalone

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13 Dec 12 Dec 11 Dec 10 Dec 09
Book Value (Rs.) 126.47 122.78 119.72 130.14 109.30 119.07 118.65 113.33 113.98 103.84 ROA 5.53% 10.37% 11.42% 12.23% 15.19% 16.56% 19.39% 10.83% 12.38% 12.07% ROE 20.15% 17.14% 15.91% 18.47% 24.38% 24.92% 29.38% 22.36% 31.51% 30.60% ROCE 31.45% 26.36% 24.14% 28.38% 38.65% 36.16% 43.00% 31.05% 46.91% 45.83% Fixed Asset Turnover 6.48 8.22 11.35 10.32 11.16 9.33 10.09 8.37 7.09 6.70 Receivable days 15.60 20.03 18.12 14.65 10.40 14.54 13.39 9.78 8.53 10.66 Inventory Days 57.56 58.34 57.72 57.50 37.61 42.77 40.75 45.18 45.27 45.93 Payable days 72.90 65.55 50.91 53.40 43.13 48.42 47.09 62.05 88.60 85.17 Cash Conversion Cycle 0.26 12.81 24.94 18.76 4.88 8.89 7.05 -7.09 -34.80 -28.58 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 1198.38 2865.01 2045.32 1368.05 1597.21 2205.05 2534.09 1830.74 1396.44 2073.36

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13 Dec 12 Dec 11 Dec 10 Dec 09
Book Value (Rs.) 126.31 121.44 118.46 128.88 107.96 117.45 118.46 114.26 115.20 105.43 ROA 5.77% 5.52% 5.23% 7.84% 15.44% 15.95% 18.82% 10.65% 12.12% 11.74% ROE 21.22% 17.26% 16.08% 18.75% 24.95% 24.10% 28.50% 22.05% 30.94% 29.77% ROCE 32.54% 26.56% 24.39% 28.82% 39.53% 35.54% 42.24% 31.05% 46.54% 45.16% Fixed Asset Turnover 6.48 8.21 11.38 9.59 9.82 8.13 8.74 7.40 6.31 5.91 Receivable days 15.60 20.03 18.09 14.59 10.35 14.45 13.29 9.62 8.38 10.45 Inventory Days 57.56 58.36 57.89 57.97 38.01 43.02 40.86 45.01 45.13 45.88 Payable days 73.24 66.11 51.51 53.81 43.72 49.18 47.40 62.14 88.58 85.41 Cash Conversion Cycle -0.07 12.28 24.47 18.75 4.64 8.28 6.75 -7.51 -35.07 -29.09 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 1232.59 2856.45 2045.74 1373.88 1612.26 2146.51 2497.59 1848.25 1403.44 2037.83

Top Investors:

lici new endowment plus-balanced fund

aditya birla sun life trustee private limited a/c aditya birla sun life tax relief 96

general insurance corporation of india

qualified institutional buyer

iepf

alternative investment fund

Annual Reports:

News Update:

GlaxoSmithkline Pharmaceuticals recalls ranitidine hydrochloride tablets
26th Sep 2019, 10:23 AM

The company has also decided to suspend release, distribution and supply of all dose to all markets, including India
Read More
GlaxoSmithkline Pharmaceuticals divests land in Mumbai
31st Aug 2019, 09:22 AM

The company has paid a sum of Rs 337.46 crore towards obtaining all required statutory and regulatory approvals
Read More
Glaxosmithkline Pharmaceuticals reports 35% rise in Q1 consolidated net profit
22nd Jul 2019, 15:22 PM

Total consolidated income of the company increased by 8.64% at Rs 818.78 crore for Q1FY20
Read More
Glaxosmithkline Phar - Quarterly Results
22nd Jul 2019, 14:40 PM

Read More
Glaxosmithkline Pharmaceuticals to focus on 20 brands, 5 therapeutic segments: Report
16th Jul 2019, 11:30 AM

The drug maker is also looking for deeper engagement with distribution channel partners and securing control over the supply chain with its own factories
Read More

Glaxosmithkline Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

BSE: 500660 | NSE: GLAXO

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Glaxosmithkline Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

BSE: 500660 | NSE: GLAXO

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: